Takeda Pharmaceutical Li... (TKPHF)

PNK: TKPHF · Real-Time Price · USD

29.85

-2.28 (-7.10%)

At close: Apr 30, 2025, 3:48 PM

Takeda Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	457.8B	533.53B	849.7B	966.22B	637.61B	702.09B	294.52B	319.45B	451.43B
Short-Term Investments	15.09B	20.17B	25.3B	36.6B	15.82B	23.28B	80.65B	56.68B	108.6B
Long-Term Investments	430.61B	378.86B	330.13B	348.35B	369.45B	306.9B	304.38B	303.05B	159.56B
Other Long-Term Assets	445.08B	63.33B	82.61B	100.34B	103.85B	87.47B	77.98B	54.41B	45.6B
Receivables	697.61B	681.69B	724.38B	812.71B	784.92B	749.12B	428.79B	356.45B	376.49B
Inventory	1,209.9B	986.46B	853.17B	753.88B	759.6B	986.74B	212.94B	226.29B	254.01B
Other Current Assets	178.21B	302.54B	273.26B	285.3B	401.51B	713.59B	129.86B	301.78B	183.26B
Total Current Assets	2,558.6B	2,398B	2,593.6B	2,712.9B	2,469.4B	3,050.7B	1,078.8B	1,260.7B	1,373.8B
Property-Plant & Equipment	1,989.8B	1,691.2B	1,582.8B	1,453.9B	1,386.4B	1,316.5B	536.8B	530.15B	551.92B
Goodwill & Intangibles	9,684.7B	9,060.4B	8,226.3B	7,943B	8,183.9B	9,021.8B	2,043.5B	2,088.5B	1,522.4B
Total Long-Term Assets	12,550.2B	11,559.8B	10,584.4B	10,199.4B	10,351.7B	10,821.7B	3,027.7B	3,095.1B	2,450.3B
Total Assets	15,108.8B	13,957.8B	13,178B	12,912.3B	12,821.1B	13,872.3B	4,106.5B	4,355.8B	3,824.1B
Account Payables	319.95B	307.45B	295.93B	232.1B	211.63B	212.35B	133.71B	125.71B	135.21B
Deferred Revenue	n/a	740.74B	644.42B	616.48B	587.98B	627.26B	200.47B	206.38B	158.47B
Short-Term Debt	367.25B	339.6B	203.99B	22.15B	586.82B	984.95B	18M	545.03B	228.46B
Other Current Liabilities	1,559.7B	1,775.3B	1,591.9B	1,468.7B	1,336.4B	686.37B	601.66B	695.35B	490.18B
Total Current Liabilities	2,313.1B	2,481.9B	2,145.7B	1,773.2B	2,175.9B	2,510.9B	737.51B	1,366.1B	857.21B
Long-Term Debt	4,476.5B	4,042.7B	4,141.4B	4,613.2B	4,506.5B	4,766B	985.64B	599.86B	539.76B
Other Long-Term Liabilities	1,045.2B	450.55B	576.31B	731.2B	833.69B	1,000.8B	199.23B	267.67B	246B
Total Long-Term Liabilities	5,521.7B	5,121.1B	5,348.8B	5,961.9B	5,917.7B	6,197.8B	1,351.5B	1,040.7B	955.67B
Total Liabilities	7,834.8B	7,603.1B	7,494.5B	7,735.1B	8,093.6B	8,708.7B	2,089.1B	2,406.8B	1,812.9B
Total Debt	5,463.4B	4,382.3B	4,345.4B	4,635.4B	5,093.3B	5,751B	985.66B	1,144.9B	768.22B
Common Stock	1,676.6B	1,676.3B	1,676.3B	1,668.1B	1,668.1B	1,643.6B	168.65B	140.18B	133.59B
Retained Earnings	1,391.2B	1,541.1B	1,479.7B	1,509.9B	1,370B	1,569.4B	1,557.3B	1,511.8B	1,523.1B
Comprehensive Income	n/a	1,508.1B	934.17B	366.11B	92.56B	349.88B	-4.79B	291B	327.94B
Shareholders Equity	7,273.3B	6,354.1B	5,683B	5,173B	4,723.5B	5,159.6B	1,997.4B	1,894.3B	1,948.7B
Total Investments	445.7B	399.03B	355.44B	384.95B	385.28B	330.18B	385.03B	359.73B	268.16B